| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0059 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0086 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |